First Hawaiian Bank Gilead Sciences, Inc. Transaction History

First Hawaiian Bank

$3.05 Billion
Q3 2024

A detailed history of First Hawaiian Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Hawaiian Bank holds 55,938 shares of GILD stock, worth $5.18 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

55,938

Previous 56,247 0.55%

Holding current value

$5.18 Million

Previous $3.86 Million 21.48%

% of portfolio

0.15%

Previous 0.13%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$66.59 - $83.99 $20,576 - $25,952	-309 Reduced 0.55%	55,938 $4.69 Million
Q2 2024 Jul 02, 2024	BUY	$63.15 - $72.88 $1,578 - $1,822	25 Added 0.04%	56,247 $3.86 Million
Q1 2024 Apr 05, 2024	SELL	$71.58 - $87.29 $68,859 - $83,972	-962 Reduced 1.68%	56,222 $4.12 Million
Q4 2023 Jan 08, 2024	BUY	$73.27 - $83.09 $38,246 - $43,372	522 Added 0.92%	57,184 $4.63 Million
Q3 2023 Oct 10, 2023	BUY	$73.94 - $80.67 $35,121 - $38,318	475 Added 0.85%	56,662 $4.25 Million
Q2 2023 Jul 06, 2023	BUY	$76.01 - $86.7 $730,532 - $833,273	9,611 Added 20.64%	56,187 $4.33 Million
Q1 2023 Apr 18, 2023	SELL	$77.31 - $88.08 $228,992 - $260,892	-2,962 Reduced 5.98%	46,576 $3.86 Million
Q4 2022 Jan 12, 2023	SELL	$62.32 - $89.47 $46,615 - $66,923	-748 Reduced 1.49%	49,538 $4.25 Million
Q3 2022 Oct 05, 2022	SELL	$59.54 - $68.01 $52,097 - $59,508	-875 Reduced 1.71%	50,286 $3.1 Million
Q2 2022 Jul 22, 2022	BUY	$57.72 - $65.01 $5,772 - $6,501	100 Added 0.2%	51,161 $3.16 Million
Q1 2022 Apr 06, 2022	SELL	$57.92 - $72.58 $5,270 - $6,604	-91 Reduced 0.18%	51,061 $3.04 Million
Q4 2021 Jan 12, 2022	BUY	$64.88 - $73.64 $3.11 Million - $3.53 Million	47,899 Added 1472.46%	51,152 $3.71 Million
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $220,195 - $237,566	3,253 New	3,253 $227,000
Q2 2021 Jul 08, 2021	SELL	$63.47 - $69.35 $273,619 - $298,967	-4,311 Closed	0 $0
Q1 2021 Apr 09, 2021	BUY	$60.0 - $68.46 $5,520 - $6,298	92 Added 2.18%	4,311 $279,000
Q4 2020 Jan 12, 2021	SELL	$56.65 - $64.55 $9,743 - $11,102	-172 Reduced 3.92%	4,219 $246,000
Q3 2020 Oct 06, 2020	SELL	$62.1 - $78.08 $435,445 - $547,496	-7,012 Reduced 61.49%	4,391 $278,000
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $850,646 - $987,756	-11,759 Reduced 50.77%	11,403 $877,000
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $861,538 - $1.1 Million	-13,756 Reduced 37.26%	23,162 $1.73 Million
Q4 2019 Jan 13, 2020	SELL	$61.62 - $67.78 $33,952 - $37,346	-551 Reduced 1.47%	36,918 $2.4 Million
Q3 2019 Oct 03, 2019	BUY	$62.51 - $69.0 $300,860 - $332,097	4,813 Added 14.74%	37,469 $2.38 Million
Q2 2019 Jul 15, 2019	BUY	$61.87 - $69.38 $1.33 Million - $1.49 Million	21,473 Added 192.01%	32,656 $2.21 Million
Q1 2019 Apr 02, 2019	SELL	$62.53 - $70.05 $1.85 Million - $2.08 Million	-29,641 Reduced 72.61%	11,183 $727,000
Q4 2018 Jan 11, 2019	SELL	$60.54 - $79.0 $217,338 - $283,610	-3,590 Reduced 8.08%	40,824 $2.55 Million
Q3 2018 Oct 16, 2018	BUY	$71.28 - $78.92 $3.17 Million - $3.51 Million	44,414 New	44,414 $3.43 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.

Account

First Hawaiian Bank Gilead Sciences, Inc. Transaction History